SamanTree Medical lands €20 million from EIB
Belgian MedTech innovator SamanTree Medical, based in Liège, has secured €20 million in financing from the European Investment Bank (EIB) to accelerate the development and commercial roll-out of its real-time surgical imaging technology. The funding aims to speed up clinical adoption of the company’s advanced confocal microscopy platform, designed to give surgeons rapid, high-resolution views of tissue during operations.
Real-time imaging for more precise surgery
At the core of the investment is SamanTree Medical’s flagship device, the Histolog Scanner. This advanced scanner provides rapid imaging of the internal microstructure of tissue samples directly in the operating room, helping surgeons assess tumour margins and other critical structures without waiting for traditional pathology results.
By enabling real-time, high-resolution imaging, the technology has the potential to reduce repeat surgeries, improve patient outcomes and cut costs for hospitals. The scanner leverages confocal microscopy to deliver detailed images that can support faster and more accurate surgical decisions.
Strategic backing under the InvestEU programme
The operation is backed by InvestEU, the European Union’s flagship programme designed to mobilise over €372 billion in additional investment between 2021 and 2027. Through this framework, the EIB channels growth capital into high-impact innovations in healthcare, deep tech and infrastructure across the bloc.
CEO Olivier Delporte described the financing as a pivotal step for the company, noting that the capital will accelerate development of the Histolog Scanner and support expansion across Europe and the United States. The rigorous due diligence carried out by the EIB is viewed internally as validation of SamanTree Medical’s technology roadmap, regulatory strategy and long-term vision for transforming surgical imaging.
Scaling MedTech innovation from Belgium
With this new funding, SamanTree Medical plans to strengthen its engineering capabilities, expand clinical partnerships and deepen market penetration in key surgical disciplines such as oncology and breast cancer surgery. The deal underscores Belgium’s growing role as a hub for MedTech and digital health innovation in Europe, particularly in technologies that combine advanced optics, medical imaging and data-driven decision support in the operating room.